First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): Practical aspects concerning its implementation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 3, 2010, Pages 453-461

  Garin, Etienne ^a,b   Rolland, Yan ^a   Boucher, Eveline ^a   Ardisson, Valérie ^a   Laffont, Sophie ^a   Boudjema, Karim ^b,c   Bourguet, Patrick ^a,b   Raoul, Jean Luc ^a,b  

^a Eugene Marquis Comprehensive Cancer Center   (France)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Hepatocellular carcinoma; Internal radiation therapy; Radioembolization; Yttrium 90

Indexed keywords

MACROSALB TC 99M; RADIOACTIVE MICROSPHERE; YTTRIUM 90;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; FEMALE; HEPATIC RADIOEMBOLIZATION; HUMAN; LIVER CELL CARCINOMA; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PULMONARY SHUNT; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INJECTIONS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PHYSICIANS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 77949262322     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1279-6     Document Type: Article

References (16)

1. Garin E, Bourguet P. Radiolipiodol of liver tumors. Use of labelled lipiodol in the treatment of hepatic tumors. In: Ell PJ, Gambhir SS, editors. Nuclear medicine in clinical diagnosis and treatment. 3rd ed, vol 1. Edinburgh: Elsevier Science; 2004. p. 473-483.
2. JL Raoul E Boucher D Olivier A Guilligomar'ch K Boudjema E Garin 2006 Association of cisplatin (CDDP) and intraarterial injection of 131I-lipiodol in the treatment of hepatocellular carcinoma: results of a phase II trial Int J Radiat Oncol Biol Phys 64 3 745 750 1:CAS:528:DC%2BD28XhtVCrtrs%3D 16289908
3. JL Raoul D Guyader JF Bretagne R Duvauferrier P Bourguet D Bekhechi, et al. 1994 Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support J Nucl Med 35 1782 1787 1:STN:280:DyaK2M%2FlsVCrsw%3D%3D 7525901
4. JL Raoul D Guyader JF Bretagne JF Heautot R Duvauferrier P Bourguet, et al. 1997 Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled iodized oil in the treatment of hepatocellular carcinoma Hepatology 26 1156 1161 1:CAS:528:DyaK2sXntl2jtrY%3D 9362356
5. S Houle TCK Yip FA Shepherd LE Rotstein KW Sniderman E Theis, et al. 1989 Hepatocellular carcinoma: a pilot trial of treatment with Y-90 microspheres Radiology 172 857 860 1:STN:280:DyaL1MzmslyltQ%3D%3D 2549567
6. FA Shepherd LE Rotstein S Houle TCK Yip K Paul KW Sniderman 1992 A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma Cancer 70 2250 2254 10.1002/1097-0142(19921101)70: 9<2250::AID-CNCR2820700906>3.0.CO;2-4 1:STN:280:DyaK3s%2FgslOlug%3D%3D 1327493
7. R Salem KG Thurston BI Carr JE Goin JF Geschwind 2002 Yttrium-90 microspheres: radiation therapy for unresectable liver cancer J Vasc Interv Radiol 13 9 Pt 2 S223 S229 10.1016/S1051-0443(07)61790-4 12354840
8. R Salem KG Thurston 2006 Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations J Vasc Interv Radiol 17 8 1251 1278 16923973 (Pubitemid 44259009)
9. DM Liu R Salem JT Bui A Courtney O Barakat Z Sergie, et al. 2005 Angiographic considerations in patients undergoing liver-directed therapy J Vasc Interv Radiol 16 7 911 935 16002500
10. RJ Lewandowski KT Sato B Atassi RK Ryu AA Nemcek Jr L Kulik, et al. 2007 Radioembolization with 90Y microspheres: angiographic and technical considerations Cardiovasc Intervent Radiol 30 4 571 592 10.1007/s00270-007-9064- z 17516113 (Pubitemid 350092259)
11. E Garin S Laffont Y Rolland D Olivie J Lecloirec JY Herry, et al. 2003 Safe radiation exposure of medical personnel using simple radioprotection means while administering 131I-lipiodol therapy for hepatocellular carcinoma Nucl Med Commun 24 671 678 10.1097/00006231-200306000-00009 1:CAS:528: DC%2BD3sXksVWksL0%3D 12766603
12. S Ho JWY Lau TWT Leung 2001 Intrahepatic 90Y-microspheres for hepatocellular carcinoma J Nucl Med 42 1587 1589 1:STN:280: DC%2BD3MrjvFSrsA%3D%3D 11585877
13. AS Kennedy C Nutting D Coldwell J Gaiser C Drachenberg 2004 Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers Int J Radiat Oncol Biol Phys 60 5 1552 1563 1:CAS:528:DC%2BD2cXhtVKrtLzO 15590187
14. R Salem RJ Lewandowski B Atassi SC Gordon VL Gates O Barakat, et al. 2005 Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 12 1627 1639 16371529
15. JH Risse F Grünvald W Kersjes H Strunk WH Caselman H Palmedo, et al. 2000 Intraarterial HCC therapy with I-131-Lipiodol Cancer Biother Radiopharm 15 65 71 10.1089/cbr.2000.15.65 1:CAS:528:DC%2BD3cXhs1antL0%3D 10740654
16. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc, et al. 2008 SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 4 378 390 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D 18650514